FENC vs GRML

Fennec Pharmaceuticals Inc. vs Greenland Mines Ltd — Valuation Comparison 2026

FENC

Biological Products, (No Diagnostic Substances)
Fennec Pharmaceuticals Inc.
Quality
6.3
out of 10
Value Trap
6
SAFE
Price
$9.93
Last close
Models
9/13
Active
VS

GRML

Biological Products, (No Diagnostic Substances)
Greenland Mines Ltd
Quality
4.6
out of 10
Value Trap
22
SAFE
Price
$0.36
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType FENC Fair ValueFENC Upside GRML Fair ValueGRML Upside
Bayesian DCF Intrinsic $1.69 -83.0% $0.12 -66.6%
First Chicago Scenario $3.02 -69.6% $0.48 +28.7%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.17 -88.2% $0.17 -51.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for FENC vs GRML — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

FENC vs GRML — Which Stock Is More Undervalued?

FENC scores higher with a 6.3/10 quality rating vs GRML's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Fennec Pharmaceuticals Inc. (FENC) and Greenland Mines Ltd (GRML) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

FENC currently trades at $9.93 with a QOC of 6.3/10, while GRML trades at $0.36 with a QOC of 4.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).